IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Clinical trials for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) explained in plain language.
Never miss a new study
Get alerted when new IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) trials appear
Sign up with your email to follow new studies for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug showdown: which Beta-Blocker best protects ICD patients?
Disease control Recruiting nowThis study compares two common heart failure medications, carvedilol and metoprolol succinate, in 2,000 adults who have an implantable cardioverter defibrillator (ICD). Participants currently taking metoprolol will be randomly assigned to either stay on it or switch to carvedilol…
Matched conditions: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC
-
New app aims to ease anxiety for heart device patients
Symptom relief Recruiting nowThis study is testing a new online resource called Choice-ICD for people who have or are getting an implantable cardioverter defibrillator (ICD). The app includes videos, quizzes, and a forum to help patients and their families understand the device and live better with it. About…
Matched conditions: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Phase: NA • Sponsor: University of Ulster • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC